# FDA Inspection 1197696 - Hetero Drugs Limited Inhouse R&D Unit - January 27, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/hetero-drugs-limited-inhouse-rd-unit/fdd9176d-6803-47d3-8ee0-2224bfc34f7f/
Source feed: FDA_Inspections

> FDA Inspection 1197696 for Hetero Drugs Limited Inhouse R&D Unit on January 27, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1197696
- Company Name: Hetero Drugs Limited Inhouse R&D Unit
- Inspection Date: 2023-01-27
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.globalkeysolutions.net/companies/hetero-drugs-limited-inhouse-rd-unit/0c566de4-43ec-4001-a830-0728c32154a4

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c